Risk of fractures associated with treatment for benign prostate hyperplasia in men
โ Scribed by P. Vestergaard; L. Rejnmark; L. Mosekilde
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 138 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate. Normal range of NEC was determined in 62 healthy individuals and was found to be 0.26-2.2 mg/24 hours (2 SD) with a me
Traditionally, the measurement of postvoid residual urinary volume (PVR) has played a prominent role in the evaluation of men with symptoms suggestive of benign prostatic hyperplasia (BPH). This article reviews current opinions about the cause of PVR, methods and accuracy of measurement, correlation
Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and
The effects of urinary symptoms on health-related quality of life (HRQL) are important in therapeutic decision making. Few have evaluated the treatment effects on HRQL in men with benign prostatic hyperplasia (BPH), even though increased urinary symptoms are associated with greater worry, bother, an